Clinical Study of a Novel Sliding Compression Locking Plate in the Treatment of Fresh Femoral Neck Fractures

Exclusion Criteria9

• Participants who had participated in clinical studies of other drugs, biologics or medical devices before enrollment and did not reach the primary study endpoint time limit;
• The patient is known to have a history of allergy to one or more implanted materials;
• Patients determined by researchers to be physically weak or unable to tolerate surgery due to other systemic diseases;
• Active infection of the hip joint or other parts of the body is determined by the investigator;
• Diagnosed as metabolic bone disease, radiation bone disease, etc.;
• Severe hip contracture deformity or severe muscle loss fused to the functional position for a long time without pain;
• have inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.;
• The patient is mentally incapable or unable to understand the requirements of participating in the study, and it is difficult to cooperate;
• Other conditions deemed unsuitable for inclusion by the investigator.